You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
|
|---|---|
| Published in |
Annals of Neurology, December 2010
|
| DOI | 10.1002/ana.22247 |
| Pubmed ID | |
| Authors |
Martin Gunnarsson, Clas Malmeström, Markus Axelsson, Peter Sundström, Charlotte Dahle, Magnus Vrethem, Tomas Olsson, Fredrik Piehl, Niklas Norgren, Lars Rosengren, Anders Svenningsson, Jan Lycke |
| Abstract |
The impact of present disease-modifying treatments (DMTs) in multiple sclerosis (MS) on nerve injury and reactive astrogliosis is still unclear. Therefore, we studied the effect of natalizumab treatment on the release of 2 brain-specific tissue damage markers into cerebrospinal fluid (CSF) in MS patients. |
Mendeley readers
The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 260 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 57 | 21% |
| Student > Ph. D. Student | 38 | 14% |
| Student > Doctoral Student | 22 | 8% |
| Student > Master | 21 | 8% |
| Other | 19 | 7% |
| Other | 57 | 21% |
| Unknown | 53 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 109 | 41% |
| Neuroscience | 41 | 15% |
| Agricultural and Biological Sciences | 16 | 6% |
| Psychology | 10 | 4% |
| Biochemistry, Genetics and Molecular Biology | 7 | 3% |
| Other | 17 | 6% |
| Unknown | 67 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#1,676,722
of 24,991,957 outputs
Outputs from Annals of Neurology
#744
of 5,596 outputs
Outputs of similar age
#8,802
of 193,022 outputs
Outputs of similar age from Annals of Neurology
#5
of 56 outputs
Altmetric has tracked 24,991,957 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,596 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,022 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.